AGILE THERAPEUTICS INC's ticker is AGRX and the CUSIP is 00847L100. A total of 80 filers reported holding AGILE THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.25 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $116,000 | +346.2% | 237,642 | +771.4% | 0.01% | +500.0% |
| Q3 2021 | $26,000 | +52.9% | 27,272 | +109.8% | 0.00% | 0.0% |
| Q2 2021 | $17,000 | -64.6% | 13,000 | -21.6% | 0.00% | -60.0% |
| Q4 2020 | $48,000 | -79.2% | 16,588 | -78.2% | 0.01% | -87.5% |
| Q3 2020 | $231,000 | +413.3% | 76,129 | +323.4% | 0.04% | +900.0% |
| Q4 2019 | $45,000 | -48.9% | 17,979 | -69.2% | 0.00% | -20.0% |
| Q1 2019 | $88,000 | +183.9% | 58,404 | +9.3% | 0.01% | +150.0% |
| Q4 2018 | $31,000 | -3.1% | 53,447 | -38.3% | 0.00% | 0.0% |
| Q3 2018 | $32,000 | +190.9% | 86,588 | +281.3% | 0.00% | – |
| Q2 2018 | $11,000 | -85.5% | 22,706 | -23.2% | 0.00% | -100.0% |
| Q1 2018 | $76,000 | -67.2% | 29,584 | -65.7% | 0.00% | -66.7% |
| Q4 2017 | $232,000 | -38.0% | 86,316 | +3.0% | 0.01% | -36.8% |
| Q3 2017 | $374,000 | – | 83,806 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 15,919,925 | $15,301,000 | 0.22% |
| NEEDHAM INVESTMENT MANAGEMENT LLC | 735,000 | $706,000 | 0.09% |
| INVESTOR AB | 3,510,189 | $3,370,000 | 0.09% |
| GSA CAPITAL PARTNERS LLP | 586,491 | $564,000 | 0.06% |
| FIRST MIDWEST BANK TRUST DIVISION | 335,735 | $322,000 | 0.05% |
| DUMONT & BLAKE INVESTMENT ADVISORS LLC | 70,000 | $67,000 | 0.02% |
| Summit Global Investments | 126,000 | $121,000 | 0.01% |
| Ergoteles LLC | 211,611 | $203,000 | 0.01% |
| Centric Wealth Management | 10,000 | $10,000 | 0.00% |
| GRIMES & COMPANY, INC. | 99,744 | $96,000 | 0.00% |